Trial Information
A Phase 1, Multi-Dose Study of SGN-33 (Anti-huCD33 mAb; HuM195; Lintuzumab) in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
Inclusion Criteria:
1. Patients must have a diagnosis of MDS or AML.
2. Patients must have an ECOG performance status ≤ 2 and a life expectancy > 3 months.
Exclusion Criteria:
1. Patients who have received prior therapy with gemtuzumab ozogamicin (Mylotarg®) or
other anti-CD33 monoclonal antibody treatment.
2. Patients with a prior allogeneic transplant.
3. Patients with known leptomeningeal or CNS involvement of leukemia. Patients with
onset of CNS symptoms within the past 12 months will also be excluded.
4. Patients receiving chemotherapy within the last four weeks.
Type of Study:
Interventional
Study Design:
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
The incidence of adverse events and lab abnormalities.
Outcome Time Frame:
13 months
Safety Issue:
Yes
Principal Investigator
Eric Sievers, M.D.
Investigator Role:
Study Director
Investigator Affiliation:
Seattle Genetics, Inc.
Authority:
United States: Food and Drug Administration
Study ID:
SG033-0001
NCT ID:
NCT00283114
Start Date:
November 2005
Completion Date:
January 2010
Related Keywords:
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Myeloproliferative Disorders
- Chronic Myelomonocytic Leukemia
- Lintuzumab
- Antigens, CD33
- Antibodies, Monoclonal
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- Hematologic Diseases
- Myeloproliferative Disorders
- Leukemia
- Leukemia
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid
- Leukemia, Myelomonocytic, Chronic
- Myelodysplastic Syndromes
- Preleukemia
- Leukemia, Myelomonocytic, Acute
- Myeloproliferative Disorders
Name | Location |
Memorial Sloan Kettering Cancer Center |
New York, New York 10021 |
Weill Medical College of Cornell University |
New York, New York 10021 |
Rocky Mountain Cancer Center |
Denver, Colorado 80218 |
St. Vincent's Comprehensive Cancer Center |
New York, New York 10011 |
Scott & White Memorial Hospital |
Temple,, Texas 76508 |
Cancer Center of the Carolinas |
Greenville, South Carolina 29615 |
Cancer Care Specialists of Central Illinois |
Decatur, Illinois 62256 |
Indiana Oncology-Hematology Consultants |
Indianapolis, Indiana 46107 |
University of Massachusetts Medical Center |
Worcester, Massachusetts 01605 |